---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-128984"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2024-12-16T23:59:59+00:00"
generated_at: "2026-05-29T03:04:21.647748+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Petros subsidiary defaults on $7.25M note; Vivus forecloses on collateral for $2M partial satisfaction

## Summary
- Metuchen failed to pay installment due Oct 1, 2024; all obligations accelerated.
- Outstanding principal $7,246,634.90 plus interest $237,300.35 at default rate of 9%.
- Secured party Vivus LLC proposed acceptance of foreclosed collateral in partial satisfaction of $2M obligations.
- Metuchen agreed to foreclosure on Dec 13, 2024; remaining obligations continue.
- Collateral excludes a Specified License Agreement; no other terms disclosed.

## SEC filing metadata
- accession: 0001104659-24-128984
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2024-12-16T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.04, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465924128984/0001104659-24-128984-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465924128984/tm2431088d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-128984
- JSON: https://secwatch.observer/filing/0001104659-24-128984.json
- Plain text: https://secwatch.observer/filing/0001104659-24-128984.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.